TherapeuticsMD, Inc. (TXMD)
2.21
-0.03
(-1.34%)
USD |
NASDAQ |
Sep 04, 16:00
2.17
-0.04
(-1.81%)
After-Hours: 20:00
TherapeuticsMD Total Liabilities (Quarterly) : 10.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.40M |
| March 31, 2026 | 10.61M |
| December 31, 2025 | 10.78M |
| September 30, 2025 | 11.23M |
| June 30, 2025 | 11.21M |
| March 31, 2025 | 11.50M |
| December 31, 2024 | 11.45M |
| September 30, 2024 | 12.46M |
| June 30, 2024 | 12.46M |
| March 31, 2024 | 13.42M |
| December 31, 2023 | 14.02M |
| September 30, 2023 | 22.44M |
| June 30, 2023 | 22.49M |
| March 31, 2023 | 27.58M |
| December 31, 2022 | |
| September 30, 2022 | 182.18M |
| June 30, 2022 | 172.27M |
| March 31, 2022 | 273.96M |
| December 31, 2021 | 263.09M |
| September 30, 2021 | 266.99M |
| June 30, 2021 | 259.68M |
| March 31, 2021 | 248.78M |
| December 31, 2020 | 305.61M |
| September 30, 2020 | 293.32M |
| June 30, 2020 | 299.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 313.85M |
| December 31, 2019 | 256.78M |
| September 30, 2019 | 271.19M |
| June 30, 2019 | 238.46M |
| March 31, 2019 | 121.20M |
| December 31, 2018 | 114.46M |
| September 30, 2018 | 102.54M |
| June 30, 2018 | 94.35M |
| March 31, 2018 | 15.66M |
| December 31, 2017 | 13.32M |
| September 30, 2017 | 10.88M |
| June 30, 2017 | 13.29M |
| March 31, 2017 | 14.09M |
| December 31, 2016 | 14.98M |
| September 30, 2016 | 12.47M |
| June 30, 2016 | 9.339M |
| March 31, 2016 | 9.596M |
| December 31, 2015 | 10.67M |
| September 30, 2015 | 12.90M |
| June 30, 2015 | 12.67M |
| March 31, 2015 | 11.77M |
| December 31, 2014 | 10.69M |
| September 30, 2014 | 11.01M |
| June 30, 2014 | 6.948M |
| March 31, 2014 | 6.819M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.53M |
| Shareholders Equity (Quarterly) | 27.13M |
| Debt to Equity Ratio | 0.2049 |
| Current Ratio | 2.756 |
| Net Debt Paydown Yield | 1.10% |